- Easy Tracking In The Watchlist
High volatility in Protagenic Therapeutics, Inc. Common stock price on Monday which ended trading at $0.219
(Updated on Jul 27, 2026)
The Protagenic Therapeutics, Inc. Common stock price gained 1.76% on the last trading day (Monday, 27th Jul 2026), rising from $0.216 to $0.219. During the last trading day the stock fluctuated 40.86% from a day low at $0.177 to a day high of $0.250. The price has been going up and down for this period, and there has been a -15.62% loss for the last 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 12 thousand more shares were traded than the day before. In total, 12 thousand shares were bought and sold for approximately $2.55 thousand.
The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -59.50% during the next 3 months and, with a 90% probability hold a price between $0.0160 and $0.160 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.
PTIX Signals & Forecast
There are mixed signals in the stock today. The Protagenic Therapeutics, Inc. Common stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $0.229 and $0.337. A break-up above any of these levels will issue buy signals. A buy signal was issued from a pivot bottom point on Wednesday, July 08, 2026, and so far it has risen 21.89%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Protagenic Therapeutics, Inc. Common has increased volume and follows the last lift in the price. This is considered to be a technical positive sign as volume should follow the price-formation. The very low volume increases the risk and reduces the other technical signals issued.
Support, Risk & Stop-loss for Protagenic Therapeutics, Inc. Common stock
Protagenic Therapeutics, Inc. Common finds support from accumulated volume at $0.216 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $0.0725 between high and low, or 40.86%. For the last week, the stock has had daily average volatility of 15.07%.
Our recommended stop-loss: $0.211 (-3.86%) (This stock has very high daily movements and this gives very high risk. There is a buy signal from a pivot bottom found 13 days ago.)
Trading Expectations (PTIX) For The Upcoming Trading Day Of Tuesday 28th
For the upcoming trading day on Tuesday, 28th we expect Protagenic Therapeutics, Inc. Common Stock to open at $0.216, and during the day (based on 14 day Average True Range), to move between $0.204 and $0.235, which gives a possible trading interval of +/-$0.0308 (+/-15.10%) up or down from last closing price. If Protagenic Therapeutics, Inc. Common Stock takes out the full calculated possible swing range there will be an estimated 15.10% move between the lowest and the highest trading price during the day.
Since the stock is closer to the support from accumulated volume at $0.216 (1.73%) than the resistance at $0.230 (4.83%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..
Is Protagenic Therapeutics, Inc. Common Stock stock A Buy?
Protagenic Therapeutics, Inc. Common holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.
Current score:
0.000
Hold/Accumulate
Unchanged
Zero in score indicates that our system is expecting high volatility and risk for the following trading day. Given the latest developments, we cannot determine the next direction as it may go both ways.
Predicted Fair Opening Price
Predicted fair opening price on July 28, 2026 - $0.216 ( 1.72%).
Want to trade but not sure how?
Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* 
*Your capital is at risk
PTIX Performance
Trading levels for PTIX
Fibonacci Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 0.288 | 31.33% |
| R2 | 0.260 | 18.71% |
| R1 | 0.243 | 10.91% |
| Price | 0.219 | |
| S1 | 0.188 | -14.35% |
| S2 | 0.171 | -22.15% |
| S3 | 0.143 | -34.77% |
Accumulated Volume Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 0 | - |
| R2 | 0.260 | 18.51% |
| R1 | 0.230 | 4.83% |
| Price | 0.219 | |
| S1 | 0.216 | -1.73% |
| S2 | 0.200 | -8.84% |
| S3 | 0.180 | -17.96% |
PTIX Dividend Payout History
| # | Ex-Date | Pay Date | Amount | Yield | |
|---|---|---|---|---|---|
| 1 | Dec 05, 2005 | Dec 05, 2005 | Dec 05, 2005 | $479,749,712.15 | 0% |
FAQ
Click here for our free guide on how to buy Protagenic Therapeutics, Inc. Common Stock Stock.
Buy PTIX